Zymeworks appoints Derek Miller to board of directors

Zymeworks Inc.

Appointed as Class II director, term expiring at 2023 annual meeting.
Received initial stock option grant for 50,000 shares of common stock.
Over 25 years biotech experience, former CBO of Celator and Aro Biotherapeutics.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Derek Miller

Director

ZYME · Zymeworks Inc.

Effective: 2023-04-10
Filed: April 10, 2023, 7:59 PM ET

voted to appoint Derek Miller as a director of the Company, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Derek Miller was appointed as Director at Zymeworks Inc..

Action: appointed
Role: Director

Exact text from the filing

voted to appoint Derek Miller as a director of the Company, effective immediately.

View on SEC.gov

Zymeworks Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-096599

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.